VEGFA and preeclampsia: SFlt (VEGR-1), which is used as a biomarker for preeclampsia in humans, can bind vascular endothelial growth factor (VEGF) which leads to an angiogenic imbalance and endothelial dysfunction (Sones & Davisson, 2016).